Zeng Di, Wang Yaoqun, Wen Ningyuan, Lu Jiong, Li Bei, Cheng Nansheng
Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Research Center for Biliary Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Front Surg. 2024 Sep 5;11:1418314. doi: 10.3389/fsurg.2024.1418314. eCollection 2024.
Re-resection is recommended for patients with incidental gallbladder carcinoma (iGBC) at T1b stage and above. It is unclear whether continuation of laparoscopic re-resection (CLR) for patients with intraoperatively detected iGBC (IDiGBC) is more beneficial to short- and long-term clinical outcomes than with conversion to radical extensive-resection (RER).
This single-centre, retrospective cohort study of patients with iGBC was conducted between June 2006 and August 2021. Patients who underwent immediate reresection for T1b or higher ID-iGBC were enrolled. Propensity score matching (PSM) was used to match the two groups (CLR and RER) of patients, and differences in clinical outcomes before and after matching were analyzed.
A total of 102 patients with ID-iGBC were included in this study. 58 patients underwent CLR, and 44 underwent RER. After 1:1 propensity score matching, 56 patients were matched to all baselines. Patients in the RER group had a lower total postoperative complication rate, lower pulmonary infection rate, and shorter operation time than those in the CLR group did. Kaplan-Meier analysis showed that the overall survival rate of patients who underwent CLR was significantly lower than that of patients who underwent RER. Multivariate analysis showed that CLR, advanced T stage, lymph node positivity, and the occurrence of postoperative ascites were adverse prognostic factors for the overall survival of patients.
Patients with ID-iGBC who underwent RER had fewer perioperative complications and a better prognosis than those who underwent CLR. For patients with ID-iGBC, conversion to radical extensive-resection appears to be a better choice.
对于T1b期及以上的意外胆囊癌(iGBC)患者,建议进行再次手术切除。目前尚不清楚,对于术中检测到的iGBC(IDiGBC)患者,持续进行腹腔镜再次切除术(CLR)与转为根治性广泛切除术(RER)相比,是否对短期和长期临床结局更有益。
本研究为单中心、回顾性队列研究,研究对象为2006年6月至2021年8月期间的iGBC患者。纳入因T1b期或更高分期的ID-iGBC而立即接受再次手术切除的患者。采用倾向评分匹配(PSM)对两组(CLR和RER)患者进行匹配,并分析匹配前后的临床结局差异。
本研究共纳入102例ID-iGBC患者。58例行CLR,44例行RER。经过1:1倾向评分匹配后,56例患者与所有基线匹配。RER组患者的术后总并发症发生率较低、肺部感染率较低且手术时间较短。Kaplan-Meier分析显示,接受CLR的患者的总生存率显著低于接受RER的患者。多因素分析显示,CLR、T分期进展、淋巴结阳性以及术后腹水的发生是患者总生存的不良预后因素。
接受RER的ID-iGBC患者围手术期并发症较少,预后优于接受CLR的患者。对于ID-iGBC患者,转为根治性广泛切除术似乎是更好的选择。